New Invasive Assessment Measures of Coronary Artery Disease Severity

Neel Khanna1, Kathir S Subramanian, Sahil Khera

  • 1From the Department of Medicine, Division of Cardiology, Westchester Medical Center/New York Medical College, Valhalla, NY.

Cardiology in Review
|January 12, 2016
PubMed

Insights

New invasive technologies for assessing coronary artery disease, like fractional flow reserve and optical coherence tomography, show promise in guiding treatments for ischemic heart disease, but clinical outcomes remain mixed.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology

Background:

  • Ischemic heart disease (IHD) is a primary global cause of mortality.
  • Recent advancements focus on identifying vulnerable atherosclerotic plaques and hemodynamically significant lesions.
  • Improved assessment and treatment strategies for IHD are crucial.

Purpose of the Study:

  • To review the clinical utility and impact of novel invasive technologies in managing coronary artery disease (CAD).
  • To evaluate the effectiveness of fractional flow reserve (FFR), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS) in guiding interventions.
  • To assess the influence of these technologies on clinical endpoints such as mortality and revascularization rates.

Main Methods:

  • Systematic review of current literature on advanced invasive CAD assessment tools.
  • Analysis of studies utilizing FFR, IVUS, OCT, and NIRS in patient management.
  • Examination of data correlating technology use with clinical outcomes.

Main Results:

  • These technologies aid in assessing lesion significance and guiding percutaneous coronary interventions (PCI).
  • Evidence suggests improved procedural guidance and lesion characterization.
  • However, observed effects on long-term mortality and revascularization rates are inconsistent.

Conclusions:

  • Advanced invasive imaging and physiology tools offer valuable insights for CAD assessment and PCI guidance.
  • Further research is needed to optimize the application of these technologies for improved clinical outcomes.
  • The ultimate benefit on mortality and revascularization requires continued investigation.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
417
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
792
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
365
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
737
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K